Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Long-Term Debt Issuances (2016 - 2017)

Historic Long-Term Debt Issuances for Lisata Therapeutics (LSTA) over the last 8 years, with Q4 2017 value amounting to $2.0.

  • Lisata Therapeutics' Long-Term Debt Issuances fell 9999.95% to $2.0 in Q4 2017 from the same period last year, while for Sep 2018 it was $2.0, marking a year-over-year decrease of 9999.98%. This contributed to the annual value of $401000.0 for FY2017, which is 5009.32% down from last year.
  • According to the latest figures from Q4 2017, Lisata Therapeutics' Long-Term Debt Issuances is $2.0, which was down 9999.95% from $400998.0 recorded in Q1 2017.
  • Over the past 5 years, Lisata Therapeutics' Long-Term Debt Issuances peaked at $13.1 million during Q3 2014, and registered a low of -$2250.0 during Q3 2015.
  • Over the past 5 years, Lisata Therapeutics' median Long-Term Debt Issuances value was $391982.5 (recorded in 2014), while the average stood at $1.3 million.
  • As far as peak fluctuations go, Lisata Therapeutics' Long-Term Debt Issuances skyrocketed by 258875.55% in 2014, and later crashed by 10001.71% in 2015.
  • Over the past 5 years, Lisata Therapeutics' Long-Term Debt Issuances (Quarter) stood at $331606.0 in 2013, then soared by 57.97% to $523830.0 in 2014, then tumbled by 100.43% to -$2250.0 in 2015, then skyrocketed by 19428.13% to $434883.0 in 2016, then tumbled by 100.0% to $2.0 in 2017.
  • Its last three reported values are $2.0 in Q4 2017, $400998.0 for Q1 2017, and $434883.0 during Q4 2016.